Table 2 Short-term and long-term outcomes according to disease stage
All (n:367) | Stage-I (n:71) | Stage-II (n:159) | Stage 2a (n:31) Stage 2b (n:128) | Stage-III (n:78) | Stage-IV (n:19) | Stage-R (n:40) | ||
|---|---|---|---|---|---|---|---|---|
Anesthesia complication (n) | 9 (2.5 %) | 0 | 3 (1.9 %) | 2a: 0 2b: 3 (2.3 %) | 4 (5.1 %) | 2 (10.5 %) | 0 | |
Wound complications (n) | ||||||||
Infection | 20 (5.4 %) | 0 | 10 (6.3) | 2a: 2 (6.5 %) 2b: 8 (6.3 %) | 6 (7.7 %) | 2 (10.5 %) | 2 (5 %) | |
Collection | 28 (7.6 %) | 2 (2.8 %) | 7 (4.4 %) | 2a: 3 (9.7 %) 2b: 4 (3.1 %) | 11 (14.1 %) | 2 (10.5 %) | 6 (15 %) | |
Dehiscence | 14 (3.8 %) | 0 | 4 (2.5 %) | 2a:0 2b: 4 (3.1 %) | 5 (6.4 %) | 1 (5.3 %) | 4 (10 %) | |
Primary healing (n) | 320 (87.2 %) | 69 (97.2 %) | 143 (89.9 %) | 2a: 27 (87.4 %) 2b: 116 (90.6 %) | 62 (79.5 %) | 16 (84.2 %) | 30 (75 %) | |
Functional recovery time (days) | 10 (2–35) | 4 (2–7) | 10 (2–35) | 2a: 4 (2–7) 2b: 12 (7–35) | 12 (7–25) | 12 (10–14) | 12 (8–22) | |
Wound healing time (days) | 12 (10–55) | 20 (12–35) | 12 (10–55) | 2a: 22 (12–30) 2b: 10 (10–35) | 12 (10–40) | 14 (12–20) | 12 (10–22) | |
Recurrence (n) | 6 (1.6 %) | 0 | 1 (0.6) | 2a: 1 (3.2 %) 2b: 0 | 2 (2.6 %) | 1 (5.3 %) | 2 (5 %) | |